Our Conviction

Regulated industries aren't hard markets. They're defensible ones.

Healthcare, legal, and financial services are three of the largest industry segments in the US economy, and they share a common trait: every meaningful software decision requires navigating a layer of professional, regulatory, and institutional constraint that pure-play tech investors often treat as friction.

We treat it as signal.

The same compliance burden that slows down a company without domain expertise is an insurmountable moat for a company built with it. HIPAA-grade clinical integrations take years to negotiate. Bar-association approval processes for legal tech platforms are not boilerplate. Banking-grade tokenization infrastructure requires an operator who has seen regulator examinations from the inside.

Northbarn Capital was founded in 2018 with a singular thesis: vertical AI companies that encode regulatory and domain expertise into their core product will achieve sustainable advantages that generalist AI companies cannot replicate.

How We Invest

We concentrate at Series A — the stage where product-market fit in regulated verticals requires more than a demo that works. It requires institutional validation: a hospital system that has signed a business associate agreement, a law firm that has cleared security review, a bank that has passed vendor onboarding. We look for companies that have crossed these thresholds and are ready to expand their institutional customer base.

Series A focus — typically $7M–$15M check participation
Regulated-industry AI: healthcare, legal, financial services
Enterprise or institutional customer contracts in place
Team with prior domain experience — operator or regulatory background preferred
Durable workflow embedding — not substitutable by a general-purpose model

Boston as Advantage

Boston's density of teaching hospitals, academic medical centers, law schools, and financial institutions is not incidental to what we do. It gives us proximity to the domain experts and institutional buyers that regulated-industry AI companies need to validate product decisions. The relationships Northbarn has built with clinical informatics leaders, general counsels, and compliance officers at Boston-area institutions are a direct input to our diligence and portfolio support.

Building in one of these markets?

We want to understand how compliance fits into your architecture — as a constraint, a moat, or both.

Reach Us